These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 19036674

  • 1. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N, Cottrez F, Carpentier A, Miroux C, Moralès O, François V, Groux H, Auriault C, Pancré V.
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.
    Kamal SM, Graham CS, He Q, Bianchi L, Tawil AA, Rasenack JW, Khalifa KA, Massoud MM, Koziel MJ.
    J Infect Dis; 2004 Apr 01; 189(7):1140-50. PubMed ID: 15031780
    [Abstract] [Full Text] [Related]

  • 3. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
    Heeg MH, Ulsenheimer A, Grüner NH, Zachoval R, Jung MC, Gerlach JT, Raziorrouh B, Schraut W, Horster S, Kauke T, Spannagl M, Diepolder HM.
    Gastroenterology; 2009 Oct 01; 137(4):1280-8.e1-6. PubMed ID: 19596013
    [Abstract] [Full Text] [Related]

  • 4. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
    Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, Nelson DR.
    Hepatology; 2004 Nov 01; 40(5):1062-71. PubMed ID: 15486925
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR, Moharram RA, Mohamed WS, Bahnassy AA, Alam El-Din HM, Abo-Shadi MM, Zayed NA, El-Magzangy H, Abdel-Aziz AO, Esmat G.
    Eur J Gastroenterol Hepatol; 2010 Apr 01; 22(4):450-6. PubMed ID: 19858727
    [Abstract] [Full Text] [Related]

  • 7. Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus.
    Kamar N, Rostaing L, Sandres-Saune K, Selves J, Barthe C, Dubois M, Alric L, Durand D, Izopet J.
    J Med Virol; 2005 Aug 01; 76(4):482-8. PubMed ID: 15977245
    [Abstract] [Full Text] [Related]

  • 8. Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.
    Miroux C, Vausselin T, Delhem N.
    Expert Opin Biol Ther; 2010 Nov 01; 10(11):1563-72. PubMed ID: 20932226
    [Abstract] [Full Text] [Related]

  • 9. Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C.
    Ferri S, Lalanne C, Lanzoni G, Bassi M, Asioli S, Cipriano V, Pappas G, Muratori P, Lenzi M, Muratori L.
    Dig Liver Dis; 2011 Oct 01; 43(10):807-13. PubMed ID: 21684822
    [Abstract] [Full Text] [Related]

  • 10. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.
    Tseng CT, Miskovsky E, Houghton M, Klimpel GR.
    Hepatology; 2001 May 01; 33(5):1312-20. PubMed ID: 11343261
    [Abstract] [Full Text] [Related]

  • 11. Chronic hepatitis C in the advanced adult and elderly subjects.
    Gattoni A, Parlato A, Vangieri B, Bresciani M, Petraccaro M.
    Minerva Gastroenterol Dietol; 2009 Jun 01; 55(2):145-57. PubMed ID: 19305374
    [Abstract] [Full Text] [Related]

  • 12. Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 study.
    Bonilla N, Barget N, Andrieu M, Roulot D, Letoumelin P, Grando V, Trinchet JC, Ganne-Carrié N, Beaugrand M, Deny P, Choppin J, Guillet J, Ziol M.
    J Viral Hepat; 2006 Jul 01; 13(7):474-81. PubMed ID: 16792541
    [Abstract] [Full Text] [Related]

  • 13. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M, Sène D, Pol S, Bourlière M, Poynard T, Charlotte F, Cacoub P, Caillat-Zucman S.
    Hepatology; 2006 Dec 01; 44(6):1607-16. PubMed ID: 17133491
    [Abstract] [Full Text] [Related]

  • 14. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr 01; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 15. HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.
    Castello G, Scala S, Palmieri G, Curley SA, Izzo F.
    Clin Immunol; 2010 Mar 01; 134(3):237-50. PubMed ID: 19910258
    [Abstract] [Full Text] [Related]

  • 16. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.
    Claassen MA, de Knegt RJ, Tilanus HW, Janssen HL, Boonstra A.
    J Hepatol; 2010 Mar 01; 52(3):315-21. PubMed ID: 20129690
    [Abstract] [Full Text] [Related]

  • 17. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.
    Liver Transpl; 2000 Mar 01; 6(2):222-8. PubMed ID: 10719024
    [Abstract] [Full Text] [Related]

  • 18. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.
    Ward SM, Fox BC, Brown PJ, Worthington J, Fox SB, Chapman RW, Fleming KA, Banham AH, Klenerman P.
    J Hepatol; 2007 Sep 01; 47(3):316-24. PubMed ID: 17475362
    [Abstract] [Full Text] [Related]

  • 19. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
    Attallah AM, Tabll AA, El-Sadany M, Ibrahim TA, El-Dosoky I.
    Clin Exp Med; 2003 Nov 01; 3(3):181-5. PubMed ID: 14648234
    [Abstract] [Full Text] [Related]

  • 20. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR, Bahnassy AA, Abdel-Wahab SA, Khafagy MM, Loutfy SA, Radwan H, Shaarawy SM.
    J Gastroenterol Hepatol; 2009 Mar 01; 24(3):416-28. PubMed ID: 19054267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.